• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.29% Nasdaq Down 3.02%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    137.81 Down 4.47(3.14%) 2:06PM EST - Nasdaq Real Time Price
    Prev Close:142.28
    Open:138.02
    Bid:138.07 x 300
    Ask:138.27 x 100
    1y Target Est:206.11
    Beta:1.59616
    Earnings Date:Apr 21 - Apr 25 (Est.)
    Day's Range:137.47 - 141.25
    52wk Range:130.51 - 208.88
    Volume:1,185,829
    Avg Vol (3m):1,589,610
    Market Cap:31.05B
    P/E (ttm):205.68
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 3.14%31.05B
    AMGNDown 2.48%106.65B
    BAXDown 4.63%19.56B

    Key Statistics

    Forward P/E (1 yr):20.05
    P/S (ttm):12.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.21
    Quarterly EPS Est (Mar-16) :1.14
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.36

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback